BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24437950)

  • 21. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enrichment and detection of circulating tumor cells by immunomagnetic beads and flow cytometry.
    Hu L; Chen X; Chen M; Fang J; Nie J; Dai H
    Biotechnol Lett; 2021 Jan; 43(1):25-34. PubMed ID: 32959190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads.
    Kim S; Han SI; Park MJ; Jeon CW; Joo YD; Choi IH; Han KH
    Anal Chem; 2013 Mar; 85(5):2779-86. PubMed ID: 23384087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels.
    Hu Y; Fan L; Zheng J; Cui R; Liu W; He Y; Li X; Huang S
    Cytometry A; 2010 Mar; 77(3):213-9. PubMed ID: 20169594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray enabled detection and eradication of circulating tumor cells with nanoparticles.
    Hossain M; Luo Y; Sun Z; Wang C; Zhang M; Fu H; Qiao Y; Su M
    Biosens Bioelectron; 2012; 38(1):348-54. PubMed ID: 22776179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.
    Oulhen M; Pailler E; Faugeroux V; Farace F
    Methods Mol Biol; 2017; 1634():133-141. PubMed ID: 28819846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
    Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
    Pailler E; Adam J; Barthélémy A; Oulhen M; Auger N; Valent A; Borget I; Planchard D; Taylor M; André F; Soria JC; Vielh P; Besse B; Farace F
    J Clin Oncol; 2013 Jun; 31(18):2273-81. PubMed ID: 23669222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
    Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
    Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
    Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in isolation and enrichment of circulating tumor cells in microfluidic chips].
    Du J; Liu X; Xu X
    Se Pu; 2014 Jan; 32(1):7-12. PubMed ID: 24783862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S; Perraki M; Kallergi G; Kafousi M; Papadopoulos S; Kotsakis A; Pallis A; Xenidis N; Kalmanti L; Kalbakis K; Agelaki S; Kalykaki A; Stournaras C; Stathopoulos E; Georgoulias V; Mavroudis D
    Breast Cancer Res Treat; 2009 Oct; 117(3):525-34. PubMed ID: 19016323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.
    Lim LS; Hu M; Huang MC; Cheong WC; Gan AT; Looi XL; Leong SM; Koay ES; Li MH
    Lab Chip; 2012 Nov; 12(21):4388-96. PubMed ID: 22930096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation.
    Wang Z; Wu W; Wang Z; Tang Y; Deng Y; Xu L; Tian J; Shi Q
    Analyst; 2016 Jun; 141(12):3621-5. PubMed ID: 26887792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH.
    Gallerani G; Cocchi C; Bocchini M; Piccinini F; Fabbri F
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.